Case Summary:

In order to achieve the EB1-A visa, the petitioner needs to demonstrate that they have sustained national or international acclaim and that their achievements have been recognized in their field of expertise. A checklist of the criteria one needs to fulfill can easily be found on the official USCIS website. The site lists the following benchmarks for EB1-A approval:

• Evidence of receipt of lesser nationally or internationally recognized prizes or awards for excellence
•  Evidence of your membership in associations in the field which demand outstanding achievement of their members
• Evidence of published material about you in professional or major trade publications or other major media
• Evidence that you have been asked to judge the work of others, either individually or on a panel
• Evidence of your original scientific, scholarly, artistic, athletic, or business-related contributions of major significance to the field

These and several other benchmarks are shown, of which one needs to qualify at least 3 criteria to be considered for the EB1-A approval. Having years of experience working with EB1-A clients from all over the world and from every walk of life, NAILG has gathered immense knowledge about the ins and outs of the adjudication process. So whenever we get a client who wants to apply under this visa category, we try our best to hold their case up against the set norms of the USCIS.

We had an EB1-A client from India, who was an expert in molecular biology and had a Ph.D. in biological sciences as well. We took the set path forward for her case preparation and found the following information in her documents:

• She is one of the few leading neural origins of psychiatric disorders experts in molecular biology, and she has achieved a consistent and notable record of success and influence in this area of study. She is especially well-known for her work on Cell and Molecular barcoding.
• The field has recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 68 times.
• She has actively engaged her peers in the field of molecular biology by authoring and co-authoring 21 peer-reviewed scientific articles (8 of them first-authored) that have been published in international journals.
• In addition to her work as a peer reviewer, she also sits on the editorial boards of several national and international journals of repute in her field.
• Due to its great applicability in the field, her research in molecular biology has been cited 500 times in at least 53 countries making her one of the top 1% of most highly cited authors publishing on topics in Brain-Virus research over the past 9 years according to Microsoft Academic.

We were thus certain of her victory while filing her case because her merits were quite obvious. We thank our client for her trust and patience2, and we wish her the very best in all future endeavors.